Danazol alters mitochondria metabolism of fibrocystic breast Mcf10A cells
article
OA: hybrid
CC0
Abstract
Fibrocystic Breast Disease (FBD) or Fibrocystic change (FC) affects about 60% of women at some time during their life. Although usually benign, it is often associated with pain and tenderness (mastalgia). The synthetic steroid danazol has been shown to be effective in reducing the pain associated with FBD, but the cellular and molecular mechanisms for its action have not been elucidated. We investigated the hypothesis that danazol acts by affecting energy metabolism. Effects of danazol on Mcf10A cells homeostasis, including mechanisms of oxidative phosphorylation, cytosolic calcium signaling and oxidative stress, were assessed by high-resolution respirometry and flow cytometry. In addition to fast physiological responses the associated genomic modulations were evaluated by Affimetrix microarray analysis. The alterations of mitochondria membrane potential and respiratory activity, downregulation of energy metabolism transcripts result in suppression of energy homeostasis and arrest of Mcf10A cells growth. The data obtained in this study impacts the recognition of direct control of mitochondria by cellular mechanisms associated with altered energy metabolism genes governing the breast tissue susceptibility and response to medication by danazol.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (53)
- Action of danazol on plasma lipids and lipoprotein metabolism. via openalex
- A French double-blind crossover study (danazol versus placebo) in the treatment of severe fibrocystic breast disease. via openalex
- Clinical trial of danazol for benign breast disease. via openalex
- Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis via openalex
- Danazol Binding to Rat Androgen, Glucocorticoid, Progesterone, and Estrogen Receptors: Correlation With Biologic Activity via openalex
- Danazol binding to steroid receptors in human uterine endometrium via openalex
- Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro via openalex
- Danazol enhances Fas-mediated apoptosis in human endometrial epithelial cells within normal physiology via openalex
- Danazol for heavy menstrual bleeding via openalex
- Danazol-induced biochemical changes in the rat ovary. via openalex
- Danazol regulates the functions of normal human endometrial stromal cell subpopulations by modifying endometrial cytokine networks via openalex
- Danazol Suppresses Both Spontaneous and Activated Human Lymphocyte‐Mediated Cytotoxicity via openalex
- Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results via openalex
- Danazol treatment of chronic cystic mastopathy: a clinical and hormonal evaluation. via openalex
- Danazol treatment of severely symptomatic fibrocystic breast disease and long‐term follow‐up—the Hjørring project via openalex
- Direct Effect of Danazol on the DNA Synthesis and Ultrastructure of Human Cultured Endometrial Stromal Cells via openalex
- Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease. via openalex
- Efficacy of Danazol in Hematologic Disorders via openalex
- Fatal acute hepatic failure induced by danazol in a patient with endometriosis and aplastic anemia via openalex
- Hepatic damage after danazol treatment. via openalex
- Inhibition of human placental progesterone synthesis by danazol in vitro via openalex
- Progesterone receptor induction by danazol in cultured cancer cells and the rat uterus via openalex
- Review: The Mechanism of Action of Danazol, a Novel Steroid Derivative via openalex
- THE INTERACTION OF HUMAN ENDOMETRIAL AND MYOMETRIAL STEROID RECEPTORS WITH DANAZOL via openalex
- The Treatment of Benign Breast Disease with Danazol via openalex
- doi:10.3390/s120912347 via openalex
- doi:10.3109/00016348309155789 via openalex
- doi:10.1016/s0149-2918(08)80058-6 via openalex
- doi:10.1002/9780470372531.ch12 via openalex
- doi:10.1016/0002-9378(86)90421-7 via openalex
- doi:10.1007/bf02111656 via openalex
- doi:10.1002/ajh.2830360213 via openalex
- doi:10.1210/er.2012-1008 via openalex
- doi:10.1016/0002-9378(81)90611-6 via openalex
- doi:10.1055/s-2007-973428 via openalex
- doi:10.1038/nprot.2008.61 via openalex
- doi:10.1093/database/bav006 via openalex
- doi:10.1210/me.2012-1292 via openalex
- doi:10.1007/978-1-61779-382-0_3 via openalex
- W2412669740 via openalex
- W6607005292 via openalex
- W6635806307 via openalex
- W6638159739 via openalex
- W6685128893 via openalex
- W6715458637 via openalex
- W6720674957 via openalex
- doi:10.1111/j.1471-4159.2010.06741.x via openalex
- doi:10.1002/iub.37 via openalex
- doi:10.1016/0016-6480(88)90167-0 via openalex
- doi:10.1097/00003081-198206000-00019 via openalex
- doi:10.1056/nejm197612232952602 via openalex
- doi:10.1152/ajpendo.00508.2003 via openalex
- doi:10.1113/eph8802507 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T05:40:41.230350+00:00
License: CC0
· commercial use OK